Targeting antigen-specific T cells by genetically engineered antigen presenting cells: A strategy for specific immunotherapy of autoimmune disease

Jian Ming Wu, Bo Wu, Frank Guarnieri, J. Thomas August, Daniel B. Drachman

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

We describe a strategy for specific immunotherapy of autoimmune disease based on targeting the antigen-specific T cells in an experimental model of myasthenia gravis. To address the problem of heterogeneity of the T cell repertoire, we have genetically engineered antigen presenting cells (APCs) to process and present epitopes of the autoantigen, acetylcholine receptor (AChR), to the entire spectrum of AChR-specific syngeneic T cells. APCs derived from BALB/c mice were stably transfected with cDNA for the key immunogenic domain of the AChR α-subunit, flanked by sequences of the lysosome-associated membrane protein (LAMP) that direct APCs to process and present the antigen via the MHC Class II pathway. Transfected APCs strongly stimulated AChR-specific T cells from BALB/c mice. Fas ligand, or antibody to Fas, abrogated the T cell response, by inducing apoptosis of the APC- stimulated T cells. The new results of this investigation are (1) that autoreactive T cells can be effectively targeted by autologous APCs that are engineered to present the relevant autoantigen, and (2) that these specifically targeted and activated T cells can be profoundly inhibited by agents that trigger the Fas-mediated apoptosis pathway. The present findings suggest that engineering APCs for simultaneous presentation of the autoantigen and delivery of FasL will provide a powerful strategy for the elimination of autoreactive T cells. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)145-153
Number of pages9
JournalJournal of Neuroimmunology
Volume106
Issue number1-2
DOIs
StatePublished - Jul 1 2000

Keywords

  • Antigen-specific T cells
  • Autoimmune disease
  • Genetic engineering
  • Immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Targeting antigen-specific T cells by genetically engineered antigen presenting cells: A strategy for specific immunotherapy of autoimmune disease'. Together they form a unique fingerprint.

  • Cite this